Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a naturally occurring RNA transcript overlapping the HEXB gene in an antisense orientation. Antisense transcripts can regulate the expression of their sense gene through mechanisms that affect mRNA stability, processing, and chromatin state near the promoter region. Such transcripts are widespread but are not considered classical therapeutic targets like enzymes or receptors. There are no established aliases, molecular families, or clinical roles specifically attributed to this particular transcript. There is no evidence for misspelling, but the entry is incomplete for therapeutic targeting purposes, as it refers to a non-coding RNA and not a protein commonly targeted in pharmacology.
Gene expression regulation: Antisense transcription may modulate sense transcript stability, processing, and chromatin modifications affecting HEXB expression. No known drug mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to HEXB (ENSG00000306131).